Indefinite Delivery Contract SPE2DP19D0002

This single-award Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult influenza vaccines for the 2022-2023 flu season. The contract has a ceiling value of $65,825,903.80 and a period of performance from the date of award on December 31, 2021 through February 28, 2023. The original solicitation sought proposals for IDIQ contracts to supply a minimum of 100 doses and a maximum of 20 million doses of...

This IDV contract, awarded by the Defense Logistics Agency Troop Support, is for the supply of approximately 3.35 million doses of injectable influenza vaccine for the 2025-2026 flu season. The contract is a single-award indefinite quantity vehicle with a ceiling value of $25,058,634.80 and a period of performance through February 13, 2026. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The...

This federal contract IDV award from the National Acquisition Center, a civilian agency, is for the procurement of influenza virus vaccines for the 2025-2026 flu season. The prime contractor, Seqirus USA Inc., a foreign-owned, for-profit manufacturer, will deliver various influenza vaccine formulations including quadrivalent vaccines, multi-dose vials, pre-filled syringes, and specialized high-dose vaccines for different age groups and populations. The contract has a ceiling value of...

The Defense Logistics Agency Troop Support Medical awarded a single-award Indefinite Delivery Contract to Seqirus USA Inc. with a potential value of $12,954,518.10 to supply influenza virus vaccinations. Under this contract, three firm fixed price delivery orders have been issued to Seqirus USA Inc. totaling $12,710,418.40 to provide influenza virus vaccinations for the 2022-2023 flu season. The delivery orders require vaccinations be delivered to Summit, New Jersey by August 31, 2022. The...

The federal contract IDV award to Sanofi Pasteur Inc. is for the provision of influenza virus vaccines and related medical supplies to support various U.S. government agencies, including the Department of Veterans Affairs, Indian Health Service, Centers for Disease Control and Prevention, Defense Logistics Agency, Department of Health and Human Services, Department of Justice Bureau of Prisons, Smithsonian Institution, and Department of State. The 5-year single-award IDV, valued at up to...

This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The $143 million IDC is for the supply of adult influenza vaccines, and a separate $208 million IDC is for pediatric influenza vaccines, to support the CDC's nationwide immunization programs from 2022-2023. Seqirus USA Inc. has also been awarded several other high-value...

The Defense Logistics Agency Troop Support Medical awarded a single award indefinite delivery contract to Seqirus USA Inc. for the supply of injectable influenza virus vaccines. The potential value of the contract vehicle is $22.6 million to be delivered between February 2021 through February 2022. Several firm fixed price delivery orders were subsequently issued against this contract for vaccine quantities between $778 to $6.6 million to support the Agency's medical countermeasures programs....

This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency within the Department of Health and Human Services, to Seqirus USA Inc. The contract has a ceiling value of $27,015,000 and is for the delivery of adult influenza vaccines for the 2019-2020 flu season. Seqirus USA Inc., through its Seqirus USA, Inc. division, is a global biotechnology company specializing in the development, manufacturing, and delivery of influenza...

This single award IDV from the Department of Health and Human Services Centers for Disease Control and Prevention to Seqirus USA Inc. has a potential value of $129,537,700 to procure adult flu vaccines through February 2022. The originating solicitation sought to award one or more IDVs for the purchase of influenza vaccines for individuals aged 19 years and older, with a minimum order of 100 doses and maximum of 20 million doses to support adult immunization programs under Section 317(j) of...

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain, a defense agency, to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The $6.86 million single-award IDC is for the delivery of influenza virus vaccines over the period from February 2025 to February 2026. Seqirus USA Inc. is a significant federal contractor in this space, holding several large IDCs with agencies like the Department of Veterans Affairs...